Head to head
TransMedics vs Abbott Laboratories
Side-by-side on the measures that matter, with a plain-English read. Full detail: TMDX · ABT
TMDX
TransMedics
81.07+0.98%
1-year price shape — -30% over the period
Quant Rating E · 12/100
vs
ABT
Abbott Laboratories
98.73+0.58%
1-year price shape — -24% over the period
Quant Rating E · 15/100
1-year performance, rebased to 100
Abbott Laboratories edges it on the scoreable measures. Abbott Laboratories has the highest Quant Rating (15); Abbott Laboratories has done best over the past year (-24%); Abbott Laboratories pays the highest dividend yield.
| TMDX | ABT | |
|---|---|---|
| Snapshot | ||
| Sector | Medical Devices | Medical Devices |
| Last price | 81.07 | 98.73 |
| Change today | +0.98% | +0.58% |
| 1-year return | -29.6% | -24.1% |
| Market cap | $2.81B | $170.84B |
| 52-week range | 60.11 – 156.00 | 81.39 – 130.33 |
| Valuation | ||
| P/E (TTM) | 21.00 | 31.95 |
| P/E percentile, own 5-yr range | 63rd | 62nd |
| P/B | 5.43 | 3.34 |
| Dividend yield | 0.00% | 2.47% |
| Profitability & growth | ||
| EPS (TTM) | 4.87 | 3.72 |
| Net profit (TTM) | $168.87M | $6.44B |
| Revenue (TTM) | $668.47M | $46.59B |
| Revenue growth (YoY) | +20.7% | +13.0% |
| Gross margin | 58.7% | 56.6% |
| Operating margin | 12.2% | 15.8% |
| Net margin | 22.7% | 11.6% |
| Free cash flow (TTM) | $79.04M | $7.82B |
| Ownership & sentiment | ||
| Institutional ownership | 102.6% | 81.2% |
| Insider activity (12mo) | 29 buy / 20 sell | 36 buy / 12 sell |
| Short interest (% of float) | 23.0% | 1.1% |
| Analyst consensus | 86% buy / 14% hold (7) | 100% buy (14) |
| Analyst price target | $109 (+34%) | $125 (+26%) |
| StockVane view | ||
| StockVane Quant Rating | E (12) | E (15) |
| Company | ||
| Employees | 898 | 115,000 |
| Founded | 1998 | 1888 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.